August 15, 2008 - Abbott and AstraZeneca said this week they entered into an agreement for Abbott to promote AstraZeneca’s CRESTOR (rosuvastatin calcium), a medication used along with diet to reduce high cholesterol.

Under the terms of the agreement, Abbott will obtain the non-exclusive right to promote CRESTOR alongside AstraZeneca in the U.S., excluding Puerto Rico. Specific financial terms were not disclosed.

August 15, 2008 - Research indicates the feasibility of uninterrupted chest compressions during biphasic external defibrillation shock delivery using modern defibrillation equipment, which may enhance the efficacy of defibrillation and cardiocerebral resuscitation.

August 14, 2008 - Boston Scientific and FDA today informed healthcare professionals and patients of the Class I Recall of NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System, distributed from June 19, 2007 through May 5, 2008.

August 14, 2008 - TeraMedica Healthcare Technology’s Evercore Enterprise Suite has been fully tested and certified for use with IBM’s Grid Medical Archive Solution (GMAS) storage management system, TeraMedica announced yesterday.

August 14, 2008 - A new study published in the July/August 2008 issue of Journal of Women’s Health highlights the importance of women knowing their own risk factors for cardiovascular disease, and cautions that a frequently used risk assessment tool could lead to false reassurance that a woman is at low risk for heart problems.

August 14, 2008 - This week doctors at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center became the first in the nation to implement the CoHesion 3D Visualization Module, an enhancement to the state-of-the-art Hansen Robotic system used to treat cardiac arrhythmias.

With the visualization module, patients undergoing the ablation treatment for heart arrhythmias are exposed to about 30 percent less radiation than without the new technology, among other benefits.

August 14, 2008 - Arlington Medical Resources (AMR), a provider of market intelligence for the pharmaceutical and diagnostic imaging industries, found the usage of injectable perflutren microsphere ultrasound (micro-bubble) contrast agents, which help to evaluate heart wall motion, declined in the second quarter of 2008 to 22 percent of the usage just two years earlier.

August 14, 2008 - Physio-Control today said the LIFEPAK 1000 defibrillator was deployed on the International Space Station (ISS) in July as the first automated external defibrillator (AED) in space.

AEDs are easy to use devices that automatically interpret a patient’s heart rhythm and, if necessary, deliver a potentially lifesaving defibrillation shock. They have become common in places such as airplanes, health clubs, and schools and now the LIFEPAK 1000 AED will be available for NASA crew members should someone experience sudden cardiac arrest in space.

August 13, 2008 – Ion Beam Applications (IBA) and NeuroSurvival Technologies Ltd. (NST) today announced the signing of a collaboration agreement for radio-labeling and distributing APOSENSE [18F]-ML-10, NST’s novel agent for molecular imaging of apoptosis, to sites participating in multicenter clinical trials of APOSENSE [18F]-ML-10.

August 13, 2008 - Blasting stereotypes that obese people are more prone to heart disease, a new study shows there is a higher prevalence of heart problems among normal-weight individuals and a higher prevalence of metabolically healthy obese individuals than previously thought.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now